MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression

Cellular Physiology and Biochemistry

Volumn 43, Issue 6, 2017, Pages 2405-2419

  Wang, Changlin ^a   Cai, Licheng ^a   Liu, Jing ^a   Wang, Gang ^a   Li, Haoming ^a   Wang, Xiaoxiong ^a   Xu, Wanhai ^a   Ren, Minghua ^a   Feng, Li ^b   Liu, Pinghuang ^b   Zhang, Cheng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

ER stress; GRP78; MicroRNA 30a 5p; Renal cell carcinoma

Indexed keywords

GLUCOSE REGULATED PROTEIN 78; MICRORNA; MICRORNA 30A 5P; UNCLASSIFIED DRUG; ANTAGOMIR; HEAT SHOCK PROTEIN; MIRN30 MICRORNA, HUMAN; MOLECULAR CHAPERONE GRP78; SMALL INTERFERING RNA;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CANCER PROGNOSIS; CELL COUNT; CELL COUNTING KIT 8 ASSAY; CELL PROLIFERATION ASSAY; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADICAL NEPHRECTOMY; REAL TIME POLYMERASE CHAIN REACTION; RENAL CELL CARCINOMA; RENAL CELL CARCINOMA CELL LINE; SURVIVAL TIME; UNFOLDED PROTEIN RESPONSE; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL PROLIFERATION; GENETIC DATABASE; GENETICS; KAPLAN MEIER METHOD; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; AGED; ANTAGOMIRS; APOPTOSIS; BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DATABASES, GENETIC; DOWN-REGULATION; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT;

EID: 85033364225     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000484394     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Meloni-Ehrig AM: Renal cancer: Cytogenetic and molecular genetic aspects. Am J Med Genet 2002;115:164-172.
3. Youssef YM, White NM, Grigull J, Krizova A, Samy C, Mejia-Guerrero S, Evans A, Yousef GM: Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol 2011;59:721-730.
4. Ma W, Tao L, Wang X, Liu Q, Zhang W, Li Q, He C, Xue D, Zhang J, Liu C: Sorafenib Inhibits Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Macrophage Infiltration. Cell Physiol Biochem 2016;39:1837-1849.
5. Tian X, Dai S, Sun J, Jiang S, Sui C, Meng F, Li Y, Fu L, Jiang T, Wang Y, Su J, Jiang Y: Inhibition of MDM2 Re-Sensitizes Rapamycin Resistant Renal Cancer Cells via the Activation of p53. Cell Physiol Biochem 2016;39:2088-2098.
6. Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M, Cosciani Cunico S, Imbimbo C, Longo N, Martignoni G, Martorana G, Minervini A, Mirone V, Montorsi F, Schiavina R, Simeone C, Serni S, Simonato A, Siracusano S, Volpe A, Carmignani G, Foundation SP-L: Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: Are further improvements needed Eur Urol 2010;58:588-595.
7. Cohen HT, McGovern FJ: Renal-cell carcinoma. N Engl J Med 2005;353:2477-2490.
8. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
9. Cullen BR: Transcription and processing of human microRNA precursors. Mol Cell 2004;16:861-865.
10. Aguda BD: Modeling microRNA-transcription factor networks in cancer. Adv Exp Med Biol 2013;774:149-167.
11. Fritz HK, Lindgren D, Ljungberg B, Axelson H, Dahlback B: The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. Eur J Cancer 2014;50:1758-1765.
12. Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N, Nakagawa M: The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer 2012;48:827-836.
13. Zhong M, Bian Z, Wu Z: MiR-30a Suppresses Cell Migration and Invasion Through Downregulation of PIK3CD in Colorectal Carcinoma. Cell Physiol Biochem 2013;31:209-218.
14. Zhao JJ, Lin J, Zhu D, Wang X, Brooks D, Chen M, Chu ZB, Takada K, Ciccarelli B, Admin S, Tao J, Tai YT, Treon S, Pinkus G, Kuo WP, Hideshima T, Bouxsein M, Munshi N, Anderson K, Carrasco R: MiR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/beta-catenin/BCL9 pathway. Cancer Res 2014;74:1801-1813.
15. Tanic M, Yanowsky K, Rodriguez-Antona C, Andres R, Marquez-Rodas I, Osorio A, Benitez J, Martinez-Delgado B: Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene. PLoS One 2012;7:e38847.
16. Wu C, Jin B, Chen L, Zhuo D, Zhang Z, Gong K, Mao Z: MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma. Cell Signal 2013;25:1212-1221.
17. Li W, Liu C, Zhao C, Zhai L, Lv S: Downregulation of beta3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets1 network in triple-negative breast cancer. Int J Oncol 2016;48:1155-1164.
18. He R, Yang L, Lin X, Chen X, Lin X, Wei F, Liang X, Luo Y, Wu Y, Gan T, Dang Y, Chen G: MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1. Int J Clin Exp Pathol 2015;8:15632-15641.
19. Wang Z, Dai X, Chen Y, Sun C, Zhu Q, Zhao H, Liu G, Huang Q, Lan Q: MiR-30a-5p is induced by Wnt/beta-catenin pathway and promotes glioma cell invasion by repressing NCAM. Biochem Biophys Res Commun 2015;465:374-380.
20. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zollner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W, Hahn SA: MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 2012;33:732-739.
21. Igci YZ, Ozkaya M, Korkmaz H, Bozgeyik E, Bayraktar R, Ulasli M, Erkilic S, Eraydin A, Oztuzcu S: Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples. Genet Test Mol Biomarkers 2015;19:418-423.
22. Pfaffenbach KT, Lee AS: The critical role of GRP78 in physiologic and pathologic stress. Curr Opin Cell Biol 2011;23:150-156.
23. Fu W, Wu X, Li J, Mo Z, Yang Z, Huang W, Ding Q: Upregulation of GRP78 in renal cell carcinoma and its significance. Urology 2010;75:603-607.
24. Kuroda K, Horiguchi A, Asano T, Ito K, Asakuma J, Sato A, Yoshii H, Hayakawa M, Sumitomo M, Asano T: Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma. Urol Int 2011;87:450-456.
25. Lin JA, Fang SU, Su CL, Hsiao CJ, Chang CC, Lin YF, Cheng CW: Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy. Urol Oncol 2014;32:29 e21-11.
26. Wang P, Zhang N, Liang J, Li J, Han S, Li J: Micro-RNA-30a regulates ischemia-induced cell death by targeting heat shock protein HSPA5 in primary cultured cortical neurons and mouse brain after stroke. J Neurosci Res 2015;93:1756-1768.
27. Chen M, Ma G, Yue Y, Wei Y, Li Q, Tong Z, Zhang L, Miao G, Zhang J: Downregulation of the miR-30 family microRNAs contributes to endoplasmic reticulum stress in cardiac muscle and vascular smooth muscle cells. Int J Cardiol 2014;173:65-73.
28. Wei W, Yang Y, Cai J, Cui K, Li RX, Wang H, Shang X, Wei D: MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3. Cell Physiol Biochem 2016;39:1165-1176.
29. Chang CW, Yu JC, Hsieh YH, Yao CC, Chao JI, Chen PM, Hsieh HY, Hsiung CN, Chu HW, Shen CY, Cheng CW: MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer. Oncotarget 2016;7:16462-16478.
30. Matsumura K, Sakai C, Kawakami S, Yamashita F, Hashida M: Inhibition of cancer cell growth by GRP78 siRNA lipoplex via activation of unfolded protein response. Biol Pharm Bull 2014;37:648-653.
31. Chen Z, Zhang J, Zhang Z, Feng Z, Wei J, Lu J, Fang Y, Liang Y, Cen J, Pan Y, Huang Y, Zhou F, Chen W, Luo J: The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2. Cell Death Dis 2017;8:e2859.
32. Yang L, Zhao Z, Zhao S, Chen C, Cong X, Li Z, Ren M: The Clinicopathological Significance of Epigenetic Silencing of VHL Promoter and Renal Cell Carcinoma: A Meta-Analysis. Cell Physiol Biochem 2016;40:1465-1472.
33. Luo F, Shi J, Shi Q, Xu X, Xia Y, He X: Mitogen-Activated Protein Kinases and Hypoxic/Ischemic Nephropathy. Cell Physiol Biochem 2016;39:1051-1067.
34. Mathew LK, Lee SS, Skuli N, Rao S, Keith B, Nathanson KL, Lal P, Simon MC: Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2alpha activity. Cancer Discov 2014;4:53-60.
35. Chang YW, Tseng CF, Wang MY, Chang WC, Lee CC, Chen LT, Hung MC, Su JL: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer. Oncogene 2016;35:1517-1528.
36. Fang L, Gong J, Wang Y, Liu R, Li Z, Wang Z, Zhang Y, Zhang C, Song C, Yang A, Ting JP, Jin B, Chen L: MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma. J Exp Clin Cancer Res 2014;33:76.
37. Li H, Song H, Luo J, Liang J, Zhao S, Su R: Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells. J Exp Clin Cancer Res 2012;31:39.